Useful pathological tools for the surveillance and disease detection in asbestos-exposed patients;Outils anatomopathologiques de depistage et de surveillance medicale des personnes exposees l'amiante

Revue des Maladies Respiratoires

Volumn 16, Issue 6 BIS, 1999, Pages 1244-1256

  Galateau Salle, F ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Asbestosis; Carcinoma; Immunohistochemistry; Mesothelioma; Molecular markers; Thoracoscopy

Indexed keywords

ASBESTOSIS; CONFERENCE PAPER; DIAGNOSTIC TEST; DNA DETERMINATION; EARLY DIAGNOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MESOTHELIOMA; OCCUPATIONAL EXPOSURE; RELIABILITY; THORACOSCOPY; BIOPSY; ENVIRONMENTAL EXPOSURE; FRANCE; HEALTH SURVEY; LUNG DISEASE; MASS SCREENING; PATHOLOGY; PLEURA DISEASE; REVIEW;

ASBESTOSIS; BIOPSY; ENVIRONMENTAL EXPOSURE; FRANCE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG DISEASES; MASS SCREENING; PLEURAL DISEASES; POPULATION SURVEILLANCE;

EID: 0033387206     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (79)

1. EPLER GR, MC LOUD, GAESNLER EA : Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA 1982;247:617-22.
2. HOURIHANE D, LESSOF L, RICHARDSON PC : Hyaline and calcified pleural plaques as an index of exposure to asbestos. Br Med J 1966;1:1069-72.
3. HASLETON P, HAMMAR SP : Malignant mesothelioma. Current Diagnostic Pathology 1996;3:153-64.
4. WILSON GE, HASLETON PS, CHATTEIJEE AK : Desmoplastic diffuse mesothelioma. A review of 17 cases. J. Clin Pathol 1992;45:295-8.
5. MANGANON WE, CAGLE PT, CHURG, A, VOLLMER RT, ROGGLI VL : The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy. Am J Clin Pathol 1998;770:191-1992.
6. BOLEN JW, HAMMAR SP, MCNUTT MA : Reactive and neoplastic serosal tissue a light microscopic ultrastructural and immunohistochemical study. Am J. Sug Pathol 1986;70: 34-47.
7. WHITAKER D, HENDERSON DW, SHILKIN KB : The concept of mesothelioma in situ : Implications for diagnosis and histogenesis. Sem in Diag Pathol 1992;9:151-61.
8. WOLANSKI KD, WHITAKER D, SHILKIN KB, HENDERSON DW : The use of epithelial membrane antigen and silver stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses. Cancer 1998, 82:583-9.
9. HENDERSON DW, SHILKINKB, WHITAKER D : Reactive mesothelial hyperplasia vs mesothelioma including mesothelioma in situ. Am J Clin Pathol 1998;118:397-404.
10. GOODGLICK LA, KANE AB : Role of reactive oxygen metabolites in crocidolite asbestos toxicity to mouse macrophages. Cancer Res 1986 ;46:5558-66.
11. HESTERBERG TW, BARRET JC: Introduction by asbestos fibers of anaphase abnormalities mechanism for aneuploidy induction and possibly carcinogenesis. Carcinogenesis 1985;6:473-5.
12. PALEKAR LD, EYRE JF, MOST BM, COFFIN DL: Metaphase and anaphase analysis of V79 cells exposed to erionite, UICC chrysotile and UICC crocidolite. Carcinogenesis 1987;8:553-60.
13. YEGLES M, JASON X, DONG HY, RENIER A, JAURAND MC : Role of fibre characteristic on cytotoxicity and induction of anaphase/telophase aberrations in rat pleural mesothelial cells in vitro. Correlations with in vivo animal findings. Carcinogenesis 1995;16:2751-8.
14. FLETJER WL, LI FP, ANTMAN KH, TESTA JR : Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma : possible sites of tumor suppressor genes. Genes Chromosom. Cancer 1989;1:148-54.
15. CHENG JQ, JHANWAR SC, KLEIN WM, et coll. : p16 alterations and deletion mapping of 9p21-P22 in malignant mesothelioma. Cancer Res 1994;54:5547-51.
16. FRIZELLE SP, GRIM J, ZHOU P, CURIEL DT, GERARDTS J, KRATZE RA : Re-expression of p16INK4a in mesothelioma cells results in cell arrest, cell death, tumor supprssion and tumor progression. Oncogene 1998;18:3087-95.
17. KRATZE RA, OTTERSON GA, LINCOLN CE et al. : Immunohistochemical analysis of the p16INK4A cyclindependant kinase inhibitor in malignant mesothelioma. J Nat Cancer Inst 1995;87:3087-95.
18. HANSTEEN K, HILT B, LIEN JT, SKAUG V, HAUGEN A: Karyotypic changes in the preclinical and subsequent stages of malignant mesothelioma: a case report. Genet Cytogenet 1993;15:94-8.
19. BIBBO M : Look-alikes in serous effusions. Compendium on diagnostic cytology. 5th ed. Wied GL. Koss LG and Reagan JW. Ed 1983 :476-7.
20. LILLINGTON GA, GOULD MK : Identification of benign pulmonary nodules by needle biopsy Chest 1998;113:3-5.
21. LODDENKEMPER R, BOUTIN C : Thoracoscopy : present and therapeutic indications. Eur Respir J 1993;6:1544-55.
22. LODDENKEMPER R : Thoracoscopy -state of the art. Eur Respir J 1998;11:213-21.
23. COLT HG : Thoracoscopy : A prospective study of safety and outcome. Chest 1995;108:324-9.
24. LANDRENEAU RJ, MACK MJ, HAZELRIGG SR, DOWLING RD, KEENAN RJ, FERSON PF : The role of thoracoscopy in the management of intrathoracic neoplastic processes. Seminars in thoracic and Cardiovascular Surgery, 1993;5:219-28.
25. BENSARD DB, MCINTYRE RC, WARING BJ, SIMON JS : Comparison of video thoracic lung biopsy to open lung biopsy in the diagnosis of interstitial lung disease. Chest 1993;103:765-70.
26. MOLIN LJ, STEINBERG JB, LANZA LA : VATS increases costs in patients undergoing lung biopsy for interstitial lung disease. Ann Thorac Surg 1994;58:1595-98.
27. RAVINI M, FERRARO G, BARBIERI B, COLOMBO P, RIZZATO G : Changing strategies of lung biopsies in diffuse lung diseases : the impact of vidéo-assisted thoracoscopy. Eur Respir J 1998;11:99-103.
28. RIERA JR, ASTENGO-OSUNA C, LONGMATE JA, BATTIFORA : The immunohistochemical diagnostic panel for epithelial mesothelioma. Am J Surg Pathol 1997;21:1409-19.
29. ORDONNEZ NG : In search of a positive immunohistochemi-cal marker for mesothelioma : an update. Advances in Anatomic Pathology 1998;5:53-60.
30. DOGLIONI C, DEITOS AP, LAURINOV L et al. : Calrétinin : A novel immunohistochemical marker for mesothelioma. Am J Surg Pathol 1996;20:1037-46.
31. HARKIN TJ, MCGUINNESS G, GOLDRING R et al. : Differentiation of the ILO Boundary Chest Roentgenograph (0/1 to 1/0) in asbestos by High-Resolution Computed Tomography Scan, alveolitis and respiratory impairment. JOEM 1996;38:46-52.
32. ABEHSERA M, DE VUYST P, DUMORTIER P, MADANI A, WINAND C, GENEVOIS A : Thorax-pathologies dues à l'amiante. Feuillets de radiologie 1996;36:213-27.
33. CHURG A : Non neoplastic disease caused by asbestos. In Pathology of occupational lung disease. A Churg, FHY Green. 2nd ed. 1998 :277-338.
34. KAZENSTEIN, ASKIN : Surgical pathology of non neoplastic lung disease. In : Major Problem in Pathalogy 1990;13: 59-96.
35. HENDERSON DW, RANTANEN J, BARNHART S et al. : Asbestos, asbestosis, and cancer : the Helsinki criteria for diagnosis and attribution. Consensus report. Scan J Work Occup Health 1997:23S :311-6.
36. GAENSLER EA, JEDERLINIC PJ, CHURG A : Idiopathic pulmonary fibrosis in asbestos -exposed workers. Am Rev Respir Dis 1991;144:689-96.
37. ROGGLI VL : Scanning electron microscopic analysis of mineral fiber content of lung tisue in the evaluation of diffuse pulmonary fibrosis. Scan Micros 1991;5:71-83.
38. WHRIGHT JL, CAGLE P, CHURG A et at. : State of the art : disease of the small airways. Am Rev Respir Dis 1992;146:240-62.
39. CRAIGHEAD J, ABRAHAM J, CHURG A et al. : The pathology of asbestos associated diseases of the lung and pleural cavities : Diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Arch Pathol Lab Med 1982;106:544-96.
40. WHRIGHT JL, CHURG A : Severe diffuse airways disease in long term chrysotile miners. Br J Indust Med 1985;42: 556-9.
41. BEGIN R, MASSE S, SEBASTIEN P et al. : Asbestos exposure and retention as determinants of airway disease and asbestos alveolitis. Am Rev Respir Dis 1988;134:1176-81.
42. AMERICAN THORACIC SOCIETY : The diagnosis of non malignant diseases related to asbestos. Am Rev Respir Dis 1986;134:363-8.
43. BECKETT WS : Diagnosis of asbestosis. Primum no nocere. Chest 1997;111:1427-28.
44. GAENSLER EA, JEDERLINIC PJ, CHURG A : Idiopathic fibrosis in asbestos exposed workers. Am Rev Respir Dis 1991;144:689-96.
45. REYNOLDS HY : Diagnostic mangement strategies for diffuse interstitial lung disease. Chest 1998;113:192-202.
46. WILKINSON P, HANSELL DM, JANSSEN J et al. : Lung Cancer associated with asbestos exposure when there are no small opacities on the chest radiograph. Lancet 1995;345:1074-8.
47. HENDERSON DW, DE KLERK NH, HAMMAR SP et al. : Asbestos-related lung cancer : is it attribuable to asbestosis or to asbestos burden ? In : Corrin B ed. Tumors of the lung contemporary issues. Edinburgh. Churchill Livingstone, 1997 :83-118.
48. BENNET WP, COLBY T, TRAVIS DW et al. : P53 protein accumulates frequently in early bronchial neoplasia. Cancer Res 1992;53:4817-22.
49. SUNDARESAN V, GANLY P, HASLETON P et al. : P53 and chromosome 3 abnormalities characteristic of malignant lung tumors, are detectable in preinvasive lesions of the bronchus. Oncogene 1992:7:1989-97.
50. TEANUD C, NEGOESCU A, LEBAT-MOLEUR F, LEGROS Y, SOUSSI T, BRAMBILLA E : P53 immunolabeling in archival paraffin embedded tisuues : optimal protocol based on microwave heating for eight antibodies on lung carcinomas. Mod Pathol 1994;7:853-9.
51. WANG X, CHRISTIANI DC, WIENCKE JK et al. : Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure. Cancer Epidemiol Biomarkers and Prevention 1995;4:543-8.
52. BOERS JE, TEN-VELDE GPM, THUNNISSEN FBJM : P53 in squamous metaplasia : amarker for risk of respiratory tract carcinoma. Am J respir Crit Care Med 1996;153:411-6.
53. BRAMBILLA E : Biologie des lésions précancéreuses pulmonaires. In : Cancers bronchopulmonaires B. Milleron A. Depierre, ed Arnette 1998, 55-65.
54. GALATEAU-SALLE F, LUNA RE, HORIBA K et al. : Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in bronchial squamous preneoplastic lesions. Mod Pathol 1998;11:174A-1022.
55. BOLON I, BRAMBILLA E, VANDENBUNDER B et al. : Changes in the expression of matrix proteases and the transcription factor c-ets-1 during progression of precancerous bronchial lesions. Lab Invest 1996;75:1-13.
56. SHAY JW, GADZAR AF : Telomerase in the early detection of cancer. J Clin Pathol 1997;50:106-9.
57. MAO LI, EL NAGGAR AK, FAN YH et al. : Telomerase activity head and neck squamous cell carcinoma and adjacent tissues. Advances in Brief. Cancer Res 1996;56:5600-4.
58. HIYAMA K, ISHIOKA S, SHIROTANI Y et al. : Alterations in telomeric repeat lenght in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene 1995;10:937-44.
59. YASHIMA K, LITZKY L, KAISER L et al. : Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinoma. Cancer Res 1997:2373-7.
60. CALIFANO J, AHRENDT SA, MEININGER G et al. : Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res 1996;56:5720-2.
61. WIEST JS, WILBUR AF, DRABKIN H, GEMMILL R, SIDRANSKY D, ANDERSON MW : Genetic marker for early detection of lung cancer and outcome measures for response to chemoprevention. J Cell Biochem Suppl 1997;28:64-73.
62. DONG XY, LU YJ, WANG YJ, BAI JF, HAN NJ, CHENG SJ : Molecular cytogenetic alteration in the early stage at human bronchial epithelial cell carcinogenesis. J. Cell Biochem Suppl 1997;28:74-80.
63. SACCOMANO G, SAUNDERS RP, ELLIS H et al. : Concentration of carcinoma or atypical cells in sputum. Acta Cytol 1963;7:305-10.
64. WOLPAW DR : Early detection in lung cancer. Case finding ansd screening. Med ClinNorth Am 1996;80:63-82.
65. LILIENFIELD A, ARCHET P. BURNETT C et al. : An evaluation of radiologic and cytologic screening for the detection of lung cancer : a cooperative pilot study of the American Cancer Society and the Veterans Administration. Cancer Res 1966;26:2083-121.
66. FROST J, BALL W, LEVIN M et al. : Early lung cancer detection : results of the initial (prevalence) radiologic and cytologic screening in the John Hopkins study. Am Rev Respir Dis 1984;130:549-54.
67. BERLIN N, BBUNCHER C, FONTANA R et al. : The national cancer institute cooperative early lung cancer detection program. Am Rev Respir Dis 1984;130:545-9.
68. EDDY D : Finding cancer in asymptomatic people. Estimating the benefits, cost and risks. Cancer 1983;51:1440-2445.
69. KUBIK A, PARKIN D, KHLAT M et al. : Lack of benefit from semi annual screening for cancer of the lung : follow-up report of a randomized controlled trial on a population of high risk males in Czechoslovakia. Int J Cancer 1990;45:26-33.
70. GRZYBORVSKI S, COY P : Early diagnosis of carcinoma of the lung : simultaneous screening with chest x-ray and sputum cytology. Cancer 1970;25:113-20.
71. MAO L, HRUBAN J, BOYLE JO, TOCKMAN M, SIDRANSKY D : Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 1994;54:1634-7.
72. SOMERS VA, PIETERSEN AM, THEUNISSEN PH, THUNISSEN FB : Detection of K-ras point mutations in sputum from patients with adenocarcinoma of the lung by point-EXACCT. J Clin Oncol 1998;16:3061-8.
73. TOCKMAN MS, MULSHINE JL, PIANTADOSI S et al. : Prospective detection of preclinical lung cancer : Results from two studies of heterogeneous nuclear ribonucleoproteinA2/B1 overexpression. Clinical Cancer Res 1997;3:2237-46.
74. PAYNE PW, SEBO RT, DOUDKINE A et al. : Sputum screening by quantitative microscopy : A reexamination of a portion of the National Cancer Institute Cooperative early lung cancer study. Mayo Clin Proc 1997;72:697-704.
75. GRUNER OC : A study of the changes met with in the leucocytes in certain cases of malignant disease. Br J Surg 1915-1916;32:629-34.
76. NIEBURGS et al. : Systemic cellular changes in material from human and animal tissues in presence of tumors. In Transactions of the 7th Annual Meeting of the Inter-Society Cytology Council ; 1959 ; p. 137.
77. TOCKMAN MS, MULSHINE JL, SMART CR : Screening for lung cancer [letter] Ann Inter Med 1989;111:765-6.
78. BOCKING A, BIESTERFELD S, CHATELAIN R, GIEN-GERLACH G, ESSER E : Diagnosis of bronchial carcinoma on sections of paraffin embedded sputum : sensitivity and specificity of an alternative to routine cytology. Acta Cytol 1992;36:37-47.
79. Flehinger BJ, Kimmel M, Polyak T et al. : Screening for lung cancer. The Mayo lung project revisisted. Cancer 1993;1:1573-80.